Internal Medicine, Infectious Disease · Edgewood, KY
NPI
1730121237
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
20 Medical Village Dr, Suite 355
Edgewood, KY, 41017
Phone (859) 344-1512
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
615 services
Medicare patients, 2024
131
Average age 71
Drug cost, 2024
$754K
604 prescriptions
Company payments, 2025
$16.69
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dora V Savani-Blackham was code 99232 (hospital e&m - subsequent), 328 times for 93 patients. In total Dora V Savani-Blackham billed 615 services in 11 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 328 | 93 | $60.53 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 105 | 51 | $91.13 | $9,569 |
| 99222 Hospital E&M - Initial | Facility | 62 | 60 | $100.35 | $6,222 |
| 99213 Office E&M - Established | Office | 23 | 15 | $42.25 | $972 |
| 99214 Office E&M - Established | Office | 21 | 15 | $83.45 | $1,752 |
By year: 2022 $63K for 897 services; 2023 $47K for 619 services; 2024 $44K for 615 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dora V Savani-Blackham prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 92 prescriptions and refills. In total Dora V Savani-Blackham wrote 604 Medicare prescriptions that cost $754K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 92 | 92 | Under 11 | $349K |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 47 | 47 | Under 11 | $64K |
| Rosuvastatin Calcium Generic | 36 | 70 | Under 11 | $409 |
| Darunavir Generic | 29 | 29 | Under 11 | $27K |
| Isentress Raltegravir Potassium | 26 | 26 | Under 11 | $48K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 24 | 24 | Under 11 | $82K |
| Lamivudine Generic | 22 | 22 | Under 11 | $1,845 |
| Vancomycin Hcl Generic | 21 | 21 | Under 11 | $4,737 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 25 | Under 11 | $123 |
| Levofloxacin Generic | 15 | 25 | Under 11 | $738 |
| Cefazolin Sodium Generic | 14 | 14 | Under 11 | $374 |
| Viracept Nelfinavir Mesylate | 13 | 13 | Under 11 | $13K |
| Efavirenz Generic | 13 | 13 | Under 11 | $6,179 |
| Ritonavir Generic | 13 | 13 | Under 11 | $2,418 |
| Stribild Elviteg/Cob/Emtri/Tenofo Disop | 12 | 12 | Under 11 | $49K |
Brand drugs: 204 claims; generic drugs: 400 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dora V Savani-Blackham $16.69 ($16.69 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $16.69.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 1 | $16.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.